SAR441000
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR441000, covering 2025-09-10 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1]